You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

SOMOPHYLLIN-CRT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Somophyllin-crt patents expire, and what generic alternatives are available?

Somophyllin-crt is a drug marketed by Graham Dm and is included in five NDAs.

The generic ingredient in SOMOPHYLLIN-CRT is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Somophyllin-crt

A generic version of SOMOPHYLLIN-CRT was approved as theophylline by RHODES PHARMS on September 1st, 1982.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SOMOPHYLLIN-CRT?
  • What are the global sales for SOMOPHYLLIN-CRT?
  • What is Average Wholesale Price for SOMOPHYLLIN-CRT?
Summary for SOMOPHYLLIN-CRT
Drug patent expirations by year for SOMOPHYLLIN-CRT

US Patents and Regulatory Information for SOMOPHYLLIN-CRT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Graham Dm SOMOPHYLLIN-CRT theophylline CAPSULE, EXTENDED RELEASE;ORAL 087763-001 Feb 27, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Graham Dm SOMOPHYLLIN-CRT theophylline CAPSULE, EXTENDED RELEASE;ORAL 087193-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Graham Dm SOMOPHYLLIN-CRT theophylline CAPSULE, EXTENDED RELEASE;ORAL 087194-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Graham Dm SOMOPHYLLIN-CRT theophylline CAPSULE, EXTENDED RELEASE;ORAL 088382-001 Feb 27, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.